The biosensors market was valued at $17,500.0 million in 2018 and is expected to reach $38,600.2 million by 2026, registering a CAGR of 10.4% from 2019 to 2026.
Major factors driving the biosensor market include rise in chronic diseases such as diabetes, rise in biotechnology R&D, and growing demand for home care medical devices. Further, significant increase in the use of biosensors in glucose monitoring devices is driving the market growth. However, the high cost associated with these devices and the trend towards adoption of new treatment devices are the major factors hindering the market growth.
Download Free Sample PDF Now: https://www.alliedmarketresearch.com/request-sample/1476
By product, the non-wearable biosensor segment accounted for the majority of the market share in 2018, and is expected to exhibit a major growth rate in the future, as the use of these sensors increases in non-clinical applications for real-time on-site. Monitoring of various manufacturing processes.
By technology, the electrochemical biosensor segment is expected to maintain its dominance in the coming years due to its precise sensitivity and rapid response. Moreover, electrochemical biosensors can be easily integrated into lab-on-chips (LOCs) to obtain better point-of-care (POC) analytical platforms.
Asia-Pacific is expected to grow at the highest rate during the forecast period. This is attributed to the increase in biotechnology R&D in the region. Key factors driving the growth of the biosensor market in Asia-Pacific include rising per capita income in several countries, increasing government initiatives to improve the healthcare sector, and the focus of leading manufacturers on expanding their geographic presence among emerging manufacturers. Asia-Pacific countries to tap into high growth opportunities in the market.
Major Key Market Players in the Industry –
Abbott Laboratories
AgaMatrix Holdings LLC
Dow
Dupont Inc. (DuPont de Nemours, Inc.)
Hoffmann-La Roche Ltd.
General Electric (Biacore, Inc.)
LifeScan, Inc.
Medtronic Plc.
Nova Biomedical
PHC Holdings Co., Ltd. (Ascensia Diabetes Care Holdings AG)
Siemens Healthcare
For Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1476
Key findings of the study –By technology, the electrochemical biosensors segment accounted for the highest market share of 28% in 2018 and is anticipated to grow at the fastest rate during the forecast period.By product, the non-wearable segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.By region, North America was the major shareholder and accounted for the highest share of 42% in 2018.Asia-Pacific is expected to grow at a CAGR of 6.1% during the forecast period.Important Questions Being Answered by This Market Report Are –Q 1. Does the biosensor market report provide Value Chain Analysis?Q 2. What are the key trends in the biosensor market report?Q 3. What are the market values / growth % of emerging countries?Q 4. Which market holds the maximum market share of the biosensor market?Request for Customization: https://www.alliedmarketresearch.com/request-for-customization/1476Value Propositions Related To The Report:Powered with Complimentary Analyst Hours and Expert Interviews with Each ReportComprehensive quantitative and qualitative insights at segment and sub-segment level
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with vario research data tables and confirms utmost accuracy in our market forecasting. Each and ever us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive#205,
Portland, OR 97220
United StatesUSA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)5505975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com